Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 26, 2026
Resolutions from the Annual General Meeting of Novo Nordisk A/S
View original at finance.yahoo.comResolutions from the Annual General Meeting of Novo Nordisk A/S Novo Nordisk A/S Bagsværd, Denmark, 26 March 2026 – Today, Novo Nordisk A/S held its Annual General Meeting…
O que extraímos desta fonte
The claims Via News extracted from this document. We point to the source; we don't replace it.
2025 was a year of profound transformation for Novo Nordisk
60% confidenceNovo Nordisk's renewed focus, strengthened competencies and commitment to people with serious chronic diseases position them well for challenges and opportunities ahead
60% confidenceNovo Nordisk is reshaping its traditional approach to patient care and market access, needing to meet patients where they are
60% confidenceThe year ahead will test Novo Nordisk's determination and capabilities, but the company faces it with confidence
60% confidence
Data points we hold from this source
| Novo Nordisk A/S · final dividend per share | 7.95 DKK |
| Novo Nordisk A/S · dividend per share | 11.70 DKK |
| Novo Nordisk A/S · share par value | 0.10 DKK |
| Novo Nordisk A/S · authorized share repurchase limit | 10 percent |
| Novo Nordisk A/S · authorized share capital increase | 44650000 DKK |
| Novo Nordisk A/S · interim dividend per share | 3.75 DKK |